Answers are grounded in this paper and cite their sources.
New treatments for systemic lupus erythematosus (SLE) aim to improve tolerability and disease activity control over standard of care (SoC) treatment. SoC typically includes daily glucocorticoid (GC) which carries a risk of organ damage over time. This study sought to develop natural history models to identify predictors of long-term outcomes with current SoC SLE treatment.
No takes yet. Share an insight, caveat, or question.
Touma et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: